AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
There isn't enough reported data to score AAPG yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
AAPG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate AAPG's fundamentals.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
AAPG PE Valuation
AAPG has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
AAPG Forward outlook
There aren't enough analyst estimates for AAPG to show an outlook.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
AAPG Earnings Per Share
AAPG and HIMS do not have enough comparable growth data to identify a winner.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
AAPG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $44.9M | +28% |
| Q4 2025 | $50.1M | +113% |
| Q2 2025 | $35.1M | -72% |
| Q4 2024 | $23.5M | +98% |
| Q2 2024 | $123.6M | +477% |
| Q4 2023 | $11.9M | -24% |
| Q2 2023 | $21.4M | +36% |
| Q4 2022 | $15.7M | +602% |
AAPG's revenue has slid since its 2024 peak: $45M last quarter, down 64% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -249% | -272 points |
| Q4 2025 | -192% | +479 points |
| Q2 2025 | -237% | +1.6 points |
| Q4 2024 | -361% | +44 points |
| Q2 2024 | 23% | +428 points |
| Q4 2023 | -671% | +2239 points |
| Q2 2023 | -239% | +3116 points |
| Q4 2022 | -405% | +4928 points |
AAPG's operating margin was −249% last quarter, down 272 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over AAPG in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over AAPG on profitability, with a higher operating margin.
AAPG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$91.9M | -$24M |
| Q4 2025 | -$118.2M | -435% |
| Q2 2025 | -$67.9M | -$12.2M |
| Q4 2024 | $35.3M | +$90.8M |
| Q2 2024 | -$55.7M | +$6.3M |
| Q4 2023 | -$55.5M | +$11.4M |
| Q2 2023 | -$62M | +$4.8M |
| Q4 2022 | -$66.8M | +$11.3M |
AAPG has burned cash in almost every quarter: −$243M over the past year, against −$240M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
AAPG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +709K shares |
| 1 year | +26% | +19.3M shares |
| 3 years | +591% | +79.8M shares |
| 5 years | +621% | +80.4M shares |
AAPG has 93M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $1.2M |
| Q4 2025 | $208 |
| Q2 2025 | $1.4M |
| Q4 2024 | $297,374 |
| Q2 2024 | $293,840 |
| Q4 2023 | $888,722 |
| Q2 2023 | $150 |
| Q4 2022 | $2M |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over AAPG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
AAPG Net Leverage
AAPG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
AAPG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 23.5 | Neutral |
AAPG's weekly RSI is 40 (neutral) and its Stochastic is 24 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
AAPG PE vs Healthcare Sector
AAPG has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
AAPG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.1 | 0.5% below |
| 20 week MA | $16.8 | 10% below |
| 50 week MA | $21.1 | 29% below |
HIMS has stronger trend alignment. AAPG is above 0 of 3 weekly averages versus HIMS above 0 of 5.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
AAPG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $17.4 | $27.7 | +59% |
| 2026 YTD | $27.7 | $15.0 | -46% |
AAPG has finished every year since 2025 higher, and it's down 46% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over AAPG on returns for 2026, with the stronger performance.